$CYCUW

Cycurion, Inc.

2
1
0

No SEC Form 4 filings for $CYCUW in the last 30 days.

See all $CYCUW insider activity →
Med

Impressive $30 Million Annual Run Rate with Very Thin 3.2 Million Outstanding Share Structure for Cycurion, Inc. (Nasdaq: CYCU)

Cycurion, Inc. (NASDAQ: CYCU) reported a $30 million annual revenue run rate, a 29.1% gross margin, and a $54.6 million 10-year contract. The company also announced a $500,000 share repurchase plan and reduced net debt by over half since 2024. Cycurion has 3.2 million outstanding shares and expects $15-$17 million in committed revenue annually through 2028.

Cycurion shares surge 37% more after $54.6M health IT contract win

Cycurion Inc. (CYCU) shares rose 37% in premarket trading after securing a $54.6M, 10-year contract for health IT modernization, adding to a 496% gain the prior day. The deal is expected to generate over $5M in annual revenue starting November 2026. The company reported a narrowed net loss and improved gross margins in Q1 2026. Analysts maintain a Buy rating with a $7.00 price target. Cycurion also faces a Nasdaq delisting threat for failing to meet the minimum bid price requirement, with a hear

Cycurion Announces Reverse Stock Split to Maintain Nasdaq Listing

Cycurion (CYCU) completed a 1-for-8 reverse stock split, reducing shares from 25.8M to 3.23M, effective August 28, 2026. The move aims to meet Nasdaq's minimum bid price requirements, with trading continuing under the same ticker.

CYCUW sentiment & insider activity

Over the past 7 days, alphai's AI scored 3 news stories mentioning CYCUW (Cycurion, Inc.). Coverage has skewed bullish: 2 bullish, 1 neutral, and 0 bearish.

Recent CYCUW coverage spans corporate actions, technology and market movers.

What's driving CYCUW

  • Cycurion, Inc. (NASDAQ: CYCU) reported a $30 million annual revenue run rate, a 29.1% gross margin, and a $54.6 million 10-year contract. The company also announced a $500,000 share repurchase plan and reduced net debt by over half since 2024. Cycurion has 3.2 million outstanding shares and expects $15-$17 million in committed revenue annually through 2028.

    barchart.com · Sep 1, 2026

  • Cycurion Inc. (CYCU) shares rose 37% in premarket trading after securing a $54.6M, 10-year contract for health IT modernization, adding to a 496% gain the prior day. The deal is expected to generate over $5M in annual revenue starting November 2026. The company reported a narrowed net loss and improved gross margins in Q1 2026. Analysts maintain a Buy rating with a $7.00 price target. Cycurion also faces a Nasdaq delisting threat for failing to meet the minimum bid price requirement, with a hear

    scanx.trade · Aug 30, 2026

  • Cycurion (CYCU) completed a 1-for-8 reverse stock split, reducing shares from 25.8M to 3.23M, effective August 28, 2026. The move aims to meet Nasdaq's minimum bid price requirements, with trading continuing under the same ticker.

    theglobeandmail.com · Aug 29, 2026

  • Cycurion (NASDAQ: CYCU) announced a 1-for-8 reverse stock split to meet NASDAQ requirements. The company reported a gross margin increase to 29.1% and a $54.6M 10-year HHS contract. It also authorized a $500K share repurchase program and aims for profitability by Q2 2027. CEO Kevin Kelly addressed market manipulation allegations.

    minichart.com.sg · Aug 28, 2026

  • Cycurion (CYCU) announced a 1-for-8 reverse stock split and a 10-year, $54.6M deal with HHS, expected to generate over $5M in annual recurring revenue. The company reported improved gross margins (29.1% in Q2 2026 vs. 6.1% in Q2 2025) and reduced net debt. Management targets profitability by Q2 2027 and authorized a $500K share repurchase program.

    stocktitan.net · Aug 28, 2026

alphai scores every news story that mentions CYCUW with an AI model for sentiment and relevance, and aggregates insider trades from Cycurion, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CYCUW

Score

Impressive $30 Million Annual Run Rate with Very Thin 3.2 Million Outstanding Share Structure for Cycurion, Inc. (Nasdaq: CYCU)

Cycurion, Inc. (NASDAQ: CYCU) reported a $30 million annual revenue run rate, a 29.1% gross margin, and a $54.6 million 10-year contract. The company also announced a $500,000 share repurchase plan and reduced net debt by over half since 2024. Cycurion has 3.2 million outstanding shares and expects $15-$17 million in committed revenue annually through 2028.

$CYCUHigh

Cycurion shares surge 37% more after $54.6M health IT contract win

Cycurion Inc. (CYCU) shares rose 37% in premarket trading after securing a $54.6M, 10-year contract for health IT modernization, adding to a 496% gain the prior day. The deal is expected to generate over $5M in annual revenue starting November 2026. The company reported a narrowed net loss and improved gross margins in Q1 2026. Analysts maintain a Buy rating with a $7.00 price target. Cycurion also faces a Nasdaq delisting threat for failing to meet the minimum bid price requirement, with a hear

1 as margins hit 29.1%, HHS award signed – Minichart

Cycurion (NASDAQ: CYCU) announced a 1-for-8 reverse stock split to meet NASDAQ requirements. The company reported a gross margin increase to 29.1% and a $54.6M 10-year HHS contract. It also authorized a $500K share repurchase program and aims for profitability by Q2 2027. CEO Kevin Kelly addressed market manipulation allegations.

$CYCUMed

Cycurion reports margin expansion, signs $54.6M contract

Cycurion (NASDAQ:CYCU) reported Q2 2026 gross margin expansion to 29.1% from 6.1% in Q2 2025, reduced net debt by over half since 2024, and signed a $54.6M 10-year contract with HHS. The company expects $15M-$17M in committed revenue annually from 2026-2028 and aims for break-even operations by Q2 2027. It also completed two acquisitions and authorized a $500K share repurchase program.

$CYCUMed

5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate

Cycurion, Inc. (CYCU) reported Q2 2026 revenue of $3.8M, beating estimates, with a 5X gross margin improvement. The company secured a $54.6M 10-year contract and acquired Kustom's video solutions, adding $5M in annual revenue. CYCU also announced a $500K share repurchase program and patent extensions for its security technology.

Related tickers